Madrid, Spain and Heidelberg, Germany, April 21st, 2016 – SYGNIS AG (Frankfurt: LIO1; ISIN: DE000A1RFM03; Prime Standard) will announce financial results for fiscal year 2015 and publish the Company's Annual Report 2015 on April 28, 2016. On this occasion, the Company will host a conference call (conducted in English) at 10:00 Central European Time (CET) hosted by Pilar de la Huerta, CEO and CFO of SYGNIS to inform about the consolidated financial statements, important developments during the reporting period and provide a strategy update and financial outlook.
Conference Call details:
Date and time: April 28, 2016, 10:00
Interested parties can access the conference call via the following telephone numbers:
• From Germany: +49 (0) 69 7104 45598
• From Spain: +34 91 787 0777
• From the US: +1 646 843 4608
• From the UK and other countries: +44 (0) 20 3003 2666
When prompted, you will be asked to give the password “SYGNIS”.v The conference call will be supplemented by a webcast presentation which can be accessed during the call. Please dial in 5 minutes before the beginning of the event.
A conference call recording will be available in the "Investors" section of the Company’s website at www.sygnis.com.
For further information please contact:
SYGNIS AG
Pilar de la Huerta
CEO/CFO
Phone: +34 91 192 36 50
Email: pdelahuerta@sygnis.com
MC Services AG
Raimund Gabriel
Managing Partner
Phone: +49 89 210228 30
Email: raimund.gabriel@mc-services.eu
About SYGNIS AG: www.sygnis.com
SYGNIS, headquartered in Germany and Spain, specializes on the development and commercialization of innovative products for DNA amplification and sequencing. Based on its proprietary technologies, SYGNIS has developed a commercial product portfolio addressing key challenges in the fast growing fields of molecular biology and next generation sequencing applications. Key products include the TruePrime™ product line and SensiPhi®, licensed to an industry leading partner, for whole genome DNA amplification and sequencing as well as the SunScript™ Reverse Transcriptase product family to convert genetic information from RNA molecules back to DNA. SYGNIS AG is listed at the German Stock Exchange in the Prime Standard segment (Ticker: LIO1; ISIN: DE000A1RFM03).
Conference Call details:
Date and time: April 28, 2016, 10:00
Interested parties can access the conference call via the following telephone numbers:
• From Germany: +49 (0) 69 7104 45598
• From Spain: +34 91 787 0777
• From the US: +1 646 843 4608
• From the UK and other countries: +44 (0) 20 3003 2666
When prompted, you will be asked to give the password “SYGNIS”.v The conference call will be supplemented by a webcast presentation which can be accessed during the call. Please dial in 5 minutes before the beginning of the event.
A conference call recording will be available in the "Investors" section of the Company’s website at www.sygnis.com.
For further information please contact:
SYGNIS AG
Pilar de la Huerta
CEO/CFO
Phone: +34 91 192 36 50
Email: pdelahuerta@sygnis.com
MC Services AG
Raimund Gabriel
Managing Partner
Phone: +49 89 210228 30
Email: raimund.gabriel@mc-services.eu
About SYGNIS AG: www.sygnis.com
SYGNIS, headquartered in Germany and Spain, specializes on the development and commercialization of innovative products for DNA amplification and sequencing. Based on its proprietary technologies, SYGNIS has developed a commercial product portfolio addressing key challenges in the fast growing fields of molecular biology and next generation sequencing applications. Key products include the TruePrime™ product line and SensiPhi®, licensed to an industry leading partner, for whole genome DNA amplification and sequencing as well as the SunScript™ Reverse Transcriptase product family to convert genetic information from RNA molecules back to DNA. SYGNIS AG is listed at the German Stock Exchange in the Prime Standard segment (Ticker: LIO1; ISIN: DE000A1RFM03).
